239 related articles for article (PubMed ID: 8608530)
21. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status.
Xu S; Murtagh S; Han Y; Wan F; Toriola AT
JAMA Netw Open; 2024 Jan; 7(1):e2353331. PubMed ID: 38277147
[TBL] [Abstract][Full Text] [Related]
22. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.
Rauscher GH; Silva A; Pauls H; Frasor J; Bonini MG; Hoskins K
Breast Cancer Res Treat; 2017 Jun; 163(2):321-330. PubMed ID: 28251385
[TBL] [Abstract][Full Text] [Related]
23. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups.
Chu KC; Anderson WF; Fritz A; Ries LA; Brawley OW
Cancer; 2001 Jul; 92(1):37-45. PubMed ID: 11443607
[TBL] [Abstract][Full Text] [Related]
24. The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States).
Tarone RE; Chu KC
Cancer Causes Control; 2002 Feb; 13(1):7-14. PubMed ID: 11899120
[TBL] [Abstract][Full Text] [Related]
25. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.
Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C
Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132
[TBL] [Abstract][Full Text] [Related]
26. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
27. Breast lesions in black women.
Kovi J; Mohla S; Norris HJ; Sampson CC; Heshmat MY
Pathol Annu; 1989; 24 Pt 1():199-218. PubMed ID: 2654837
[TBL] [Abstract][Full Text] [Related]
28. Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities study.
John EM; Phipps AI; Hines LM; Koo J; Ingles SA; Baumgartner KB; Slattery ML; Wu AH
Int J Cancer; 2020 Oct; 147(7):1808-1822. PubMed ID: 32064598
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses.
Gleason MX; Mdzinarishvili T; Sherman S
PLoS One; 2012; 7(11):e49359. PubMed ID: 23166647
[TBL] [Abstract][Full Text] [Related]
30. Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer.
Martinez SR; Beal SH; Chen SL; Canter RJ; Khatri VP; Chen A; Bold RJ
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):787-92. PubMed ID: 20619550
[TBL] [Abstract][Full Text] [Related]
31. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
32. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
Li CI; Malone KE; Daling JR
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
[TBL] [Abstract][Full Text] [Related]
33. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis.
John EM; McGuire V; Kurian AW; Koo J; Shariff-Marco S; Gomez SL; Cheng I; Keegan THM; Kwan ML; Bernstein L; Vigen C; Wu AH
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):351-363. PubMed ID: 33355191
[TBL] [Abstract][Full Text] [Related]
34. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
35. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS
Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656
[TBL] [Abstract][Full Text] [Related]
36. Residential racial segregation and mortality among black, white, and Hispanic urban breast cancer patients in Texas, 1995 to 2009.
Pruitt SL; Lee SJ; Tiro JA; Xuan L; Ruiz JM; Inrig S
Cancer; 2015 Jun; 121(11):1845-55. PubMed ID: 25678448
[TBL] [Abstract][Full Text] [Related]
37. A Pooled Analysis of Breastfeeding and Breast Cancer Risk by Hormone Receptor Status in Parous Hispanic Women.
Sangaramoorthy M; Hines LM; Torres-Mejía G; Phipps AI; Baumgartner KB; Wu AH; Koo J; Ingles SA; Slattery ML; John EM
Epidemiology; 2019 May; 30(3):449-457. PubMed ID: 30964816
[TBL] [Abstract][Full Text] [Related]
38. Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study.
John EM; Sangaramoorthy M; Phipps AI; Koo J; Horn-Ross PL
Am J Epidemiol; 2011 Jan; 173(2):201-16. PubMed ID: 21084558
[TBL] [Abstract][Full Text] [Related]
39. Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer Population.
Kabat GC; Ginsberg M; Sparano JA; Rohan TE
J Racial Ethn Health Disparities; 2017 Dec; 4(6):1181-1188. PubMed ID: 28004356
[TBL] [Abstract][Full Text] [Related]
40. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
